These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25921475)

  • 21. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 22. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
    Martin PR; Finlayson AJ
    Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.
    Crits-Christoph P; Markell HM; Gibbons MB; Gallop R; Lundy C; Stringer M; Gastfriend DR
    J Subst Abuse Treat; 2016 Nov; 70():50-57. PubMed ID: 27692188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
    Connery HS
    Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
    Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
    Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol dependence and pharmacologic treatment. Introduction.
    McDonough KP
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S3-4. PubMed ID: 17322180
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
    Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
    Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 36. The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal Study.
    Knudsen HK; Roman PM
    J Subst Abuse Treat; 2016 Mar; 62():62-7. PubMed ID: 26689318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
    Litten RZ; Falk D; Ryan M; Fertig J
    Alcohol Clin Exp Res; 2014 Jan; 38(1):27-32. PubMed ID: 23889161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addiction disorders.
    Merrill JO; Duncan MH
    Med Clin North Am; 2014 Sep; 98(5):1097-122. PubMed ID: 25134875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
    Bramness JG; Mann K; Wurst FM
    Eur Addict Res; 2016; 22(6):318-321. PubMed ID: 27438908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.
    Bergman BG; Ashford RD; Kelly JF
    Exp Clin Psychopharmacol; 2020 Aug; 28(4):449-461. PubMed ID: 31556675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.